Back

Cost-effectiveness of primary prevention.

11 April 2019 (14:22 - 14:45)
Organised by:
Congress Presentation Part of: Cardiovascular prevention: is it worth the money? Public Health and Health Economics EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Professor Oscar Franco Duran

Institute of Social and Preventive Medicine (ISPM), Bern (Switzerland)

3 More presentations in this session

Presentation thumbnail
The economic burden of cardiovascular disease.
Professor F. Pinto (Lisbon, PT)
Slides Video
Presentation thumbnail
Cost-effectiveness of secondary prevention
Ms G. Shields (Manchester, GB)
Slides Video
Presentation thumbnail
Cost-effectiveness of telerehabilitation
Doctor I. Frederix (Heerlen, NL)
Slides Video

Access the full session

Session thumbnail
Cardiovascular prevention: is it worth the money?

The Event

Event poster

EuroPrevent 2019

11 April 2019 14:22 CET
You may be interested in
thumbnail
Congress Presentation
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation
25 August 2023
thumbnail
Congress Presentation
What would be the impact on the burden of hypertension of achieving public health goals?
1 September 2025
thumbnail
Congress Presentation
Primary prevention implantation of cardioverter defibrillators in truly asymptomatic patients: should we rethink current recommendations?
22 May 2023
thumbnail
Webinar
How to Improve Implementation of Prevention Guidelines: Barriers, Tips and Tricks
9 December 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources